Elsevier

Pancreatology

Volume 15, Issue 5, September–October 2015, Pages 570-572
Pancreatology

Case report
Mefenamic acid: A possible cause of drug-induced acute pancreatitis

https://doi.org/10.1016/j.pan.2015.08.003Get rights and content

Abstract

Introduction

Drug-induced acute pancreatitis (AP) is rare, but as there are no systematic data on it, the true incidence is not known.

Case report

This case report is a first description of two episodes of AP occurring after administration and subsequent re-administration of mefenamic acid to a young woman without comorbidities. Other common causes of AP could be ruled out. With both episodes, the latency of AP was less than 24 h after drug intake.

Conclusion

Mefenamic acid should be considered as a possible cause of drug-induced AP.

Introduction

Drug-induced acute pancreatitis (AP) is rare, reported to be 0.1–5.3% of all AP episodes [1], [2], [3], [4], though due to the lack of systematic data, the true incidence is unknown and evidence has mainly been derived from case reports and case series [5], [6]. Since drug-induced AP has no characteristic clinical course, it cannot be differentiated from other forms of AP on that basis alone. Criteria for drug-induced AP were defined 35 years ago by Mallory and Kern [7]. The number of drugs associated to AP varies from 120 to 500 [6], [8], and widely varying potencies of certain substances are reported to induce AP [8].

This case report is a first description of two episodes of AP occurring after administration and subsequent re-administration of mefenamic acid (latency of AP from drug ingestion <24 h for both episodes) to a patient without comorbidities. Other causes of AP could be ruled out systematically.

Section snippets

Case report

A 16-year-old girl with a medical history of recurrent constipation presented to the emergency department with severe abdominal pain and emesis in the evening. The symptoms had developed a few hours after oral intake of mefenamic acid, 500 mg, for the first time in her life for a severe headache at midday. No other concomitant medications were taken and no alcohol abuse was reported. Physical examination upon admission revealed abdominal tenderness but no guarding. Laboratory findings showed

Discussion

The most common causes of AP in developed countries are biliary disease (38%) or alcoholism (36%) [3].

AP induced by drugs is a rare entity that presents a diagnostic challenge, as it has no definite clinical characteristics to distinguish it from other forms of AP [7], [8], [9], [10]. Drug-induced AP was first described by Mallory and Kern in 1980 [7]. That publication postulated a key point for identifying AP as drug-induced: the development of AP after intake of the drug AND its reappearance

Source of funding

None.

Disclosure statement

The authors report nothing to disclose.

Acknowledgements

We thank Dr. Herbert Ringhofer, MD for his technical support with respect to the images presented.

We thankfully appreciate the editorial assistance provided by Eugenia Lamont, BA.

References (14)

There are more references available in the full text version of this article.

Cited by (10)

  • Central nervous system toxicity due to mefenamic acid

    2019, American Journal of Emergency Medicine
    Citation Excerpt :

    However, it has still a role in chronic pain and some pain syndromes due to its potency. Reported side effects secondary to mefenamic acid are, included but not limited to anaphylaxis, skin reactions, nephrotoxicity, drug-induced acute pancreatitis and enteropathy [7-11]. In adults and children over 12 years, maximum daily dose of mefenamic acid is 1500 mg per day.

  • Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials

    2017, Pancreatology
    Citation Excerpt :

    Second, we did not compare the adverse events with NSAIDs vs. placebo because of limited data. Previous studies have reported NSAIDs related AP [35–37]. Our study found a lower incidence of PEP in the NSAIDs group.

  • Effect of diclofenac suppository on treatment of acute biliary pancreatitis

    2020, Scientific Journal of Kurdistan University of Medical Sciences
View all citing articles on Scopus
View full text